RERE ATRenew Inc.

NYSE atrenew.com


$ 4.08 $ -0.32 (-7.27 %)    

Thursday, 20-Nov-2025 14:25:51 EST
QQQ $ 590.94 $ -20.73 (-3.39 %)
DIA $ 460.10 $ -6.58 (-1.41 %)
SPY $ 657.18 $ -15.72 (-2.34 %)
TLT $ 89.21 $ 0.22 (0.25 %)
GLD $ 375.73 $ 0.55 (0.15 %)
$ 4.03
$ 4.41
$ 4.07 x 300
$ 4.10 x 145
$ 4.08 - $ 4.44
$ 2.00 - $ 4.93
1,963,647
na
590.6M
$ 0.56
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 atrenew-sees-q4-sales-854053m-868099m

ATRenew (NYSE:RERE) sees Q4 sales of $854.053 million-$868.099 million.

 atrenew-q3-adj-eps-010-beats-005-estimate-sales-723300m-beat-665000m-estimate

ATRenew (NYSE:RERE) reported quarterly earnings of $0.10 per share which beat the analyst consensus estimate of $0.05 by 100 pe...

 preview-atrenews-earnings
Preview: ATRenew's Earnings
11/19/2025 16:01:18

 atrenew-sees-q3-sales-704953m-718912m-vs-725000m-est

ATRenew (NYSE:RERE) sees Q3 sales of $704.953 million-$718.912 million vs $725.000 million analyst estimate.

 atrenew-q2-adj-eps-009-beats-004-estimate-sales-696800m-beat-665000m-estimate

ATRenew (NYSE:RERE) reported quarterly earnings of $0.09 per share which beat the analyst consensus estimate of $0.04 by 125 pe...

 atrenew-sees-q2-2025-revenues-between-rmb4710b-and-rmb4810b-a-247-to-274-increase-yoy

ATRenew (NYSE:RERE) sees Q2 sales of $649.055 million-$662.836 million vs $4.98 billion analyst estimate.

 atrenew-q1-adj-eps-007-beats-005-estimate-sales-64130m-beat-63600m-estimate

ATRenew (NYSE:RERE) reported quarterly earnings of $0.07 per share which beat the analyst consensus estimate of $0.05 by 40 per...

 preview-atrenews-earnings
Preview: ATRenew's Earnings
05/19/2025 15:02:10

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION